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This study investigates the eﬀects of lidocaine pre-emptive treatment on neuropathic pain behavior, injury discharges of nerves,
neuropeptide Y (NPY) and c-Fos expression in the cuneate nucleus (CN) after median nerve chronic constriction injury (CCI).
Behaviortestsdemonstratedthatthepre-emptive lidocainetreatmentdosedependentlydelayedandattenuatedthedevelopmentof
mechanicalallodynia within a 28-day period. Electrophysiological recording was used to examine the changes in injury discharges
of the nerves. An increase in frequency of injury discharges was observed and peaked at postelectrical stimulation stage in the
presaline group, which was suppressed by lidocaine pre-emptive treatment in a dose-dependent manner. Lidocaine pretreatment
also reduced the number of injury-induced NPY-like immunoreactive (NPY-LI) ﬁbers and c-Fos-LI neurons within the CN in a
dose-dependent manner. Furthermore, the mean number of c-Fos-LI neurons in the CN was signiﬁcantly correlated to the NPY
reduction level and the sign of mechanical allodynia following CCI.
1.Introduction
Pre-emptive analgesia is broadly used in clinical practice for
relieving postoperation pain and preventing the subsequent
development of chronic neuropathic pain after surgery [1,
2]. In chronic constriction injuries (CCIs) of rat sciatic
nerves [3], neuropathic pain behavior was also relieved by
pre-emptive treatment of MK-801 [4], nociceptin [5], or
lidocaine [6], but little is known about the eﬀect of pre-
emptiveanalgesiaonneuropathicpainbehavioraftermedian
nerve CCI. Attenuating ectopic discharges, originating from
the damaged nerves [7, 8] and/or their dorsal root ganglia
(DRG) [9], were considered to be one of the pre-emptive
analgesia mechanisms to relieve neuropathic pain. Topical or
systemic application of local anesthetics has been reported
to attenuate ectopic discharges [9, 10]. Clinical studies
have also indicated that neuropathic pain is alleviated by
application of local anesthetics to the painful target areas
[11, 12]. Lidocaine is a local anesthetic that produces a
transient analgesic eﬀect in humans aﬀected by neuropathic
and postoperative pain [13, 14]. Local pretreatment of
lidocaine eﬀectively suppresses injury discharges induced by
median nerve transection (MNT) [15], but lack of evidence
regarding the median nerve CCI model.
Injury to median nerve, neuropeptide Y-like immunore-
active (NPY-LI) ﬁbers are dramatically induced in the lesion
side cuneate nucleus (CN), but not detected in the intact
side [16]. Furthermore, given an electrical stimulation to
theinjuredmediannerve,c-Fos-likeimmunoreactive(c-Fos-
LI) cells are detected only in the ipsilateral CN [17, 18].
The expression of Fos, which is the protein product of the
immediate-early proto-oncogene c-fos, has been accepted
as a neural marker of pain [19, 20]. Pre-emptive analgesia
treatment with lidocaine [21]e ﬀectively suppresses c-Fos2 Anesthesiology Research and Practice
expression in the spinal cord after peripheral nerve injury.
Furthermore, the expression of c-Fos is modulated by NPY
andisconsideredtobeinvolvedinneuropathicpain[22].We
previously demonstrated that lidocaine pre-treatment dose-
dependently suppressed injury discharges to reduce NPY
expression in the CN, which in turn signiﬁcantly attenuated
c-Fosexpression after MNT along with electrical stimulation
[15]. However, there is still only very little of behavioral
evidence to support the eﬀect of pre-emptive treatment on
neuropathic pain relief after median nerve CCI.
In this study, we wanted to examine whether a single
topical application of lidocaine prior to median nerves
undergoing CCI would inﬂuence the development of neuro-
pathic pain and ectopic discharges after CCI. Furthermore,
morphological changes in NPY and c-Fos expression in the
CN were examined to evaluate whether their expression
levels correlated with the degree of mechanical allodynia.
2.Materialsand Methods
The experiments were inspected and approved by the Natio-
nalScienceCouncilCommitteeandtheAnimalCenterCom-
mittee,College ofMedicine, NationalTaiwan University,Tai-
wan (IACUCA Approval no. 20030114 and no. 20080267).
Ethical guidelines from the International Association for the
Study of Pain [23] were followed in the use of animals.
Animals were housed under approved circumstances with
a 12/12h light/dark cycle with food and water available ad
libitum.
2.1. Chronic Constriction Injury (CCI) Operation. Thirty-
three male Sprague-Dawley rats (175–200g) purchased from
BioLASCO (Taiwan) were randomly divided into a control
group (sham operation, median nerve exposure without
injury, n
￿ 3), and pretreated with saline (presaline, n
￿ 10),
1% lidocaine (pre-1% lido, n
￿ 10) and 5% lidocaine (pre-
5% lido, n
￿ 10) groups along with CCI. Under chloral
hydrate anesthesia (31.5mg/100g body weight, i.p.), the
above-mentioned pretreated groups alternatively underwent
unilateral (n
￿ 5) or bilateral (n
￿ 5) median nerve CCI
operations, the nerves were carefully separated from the
surrounding tissue at the level of the elbow immediately
proximal to entering between the two heads of the pronator
teres muscle. Saline and various concentrations of lidocaine
(Sigma, St. Louis, Mo, USA) were applied topically to
the exposed median nerves (100μL) at 15min prior to
CCI. Fifteen minutes after the application of the saline or
lidocaine, four ligatures of 4.0 chromic gut were tied loosely
around thenerves[3,17, 22]. Aftertheoperation, thewound
was subsequently sutured.
2.2. Behavior Assessment. We examined the behavioral signs
with mechanical stimulation between 09:00 and 17:00 at
one day before (
￿1) and at 3, 7, 14, 21, and 28 days after
CCI to the median nerves of the pre-treatment groups,
controls, or uninjured contralateral forepaw. All behavioral
measurements were obtained by an investigator blind to the
treatment groups.
Mechanical allodynia was estimated by means of Von
Frey ﬁlaments [24]. Von Frey ﬁlaments (Somedic Sales AB,
H¨ orby, Sweden) of diﬀerent bending forces including 0.145,
0.32, 0.39, 1.1, 1.7, 3.3, 5.1, 8.3, 17, and 24g were used to
test the mechanical threshold of the rat forepaws [17, 22].
Brieﬂy, tests were started with the smallest bending force and
continued in increasing order. Each ﬁlament was applied ﬁve
times in the medial surface of a forepaw; the ﬁrst ﬁlament in
the series that elicited withdraw three times was regarded as
the paw withdrawal threshold. The thresholds of individual
rats in each group were averaged and presented as mean and
the standard error of the mean (mean
￿ SEM).
2.3. Electrical Stimulation and Electrophysiological Recording.
On the 29th day post-CCI operation, the right nerves of the
control and CCI rats were reexposed under anesthesia and at
least a 12mm segment proximalto theCCIligature oron the
same levelin the controlgroup were isolated. Then, two pairs
of platinum hook electrodes were placed on the nerve; the
distal pair of the hook electrodes were connected to a Grass
S88 stimulator (Grass, Quincy, Mass, USA) for electrical
stimulation, and the proximal pair of hook electrodes were
connected to an Xction View Data Acquisition System
(Model XD-04; Singa, Tao Yuan, Taiwan) for recording.
Warm paraﬃn oil was applied around the exposed nerves
to prevent them from drying out. The discharges in the
median nerve at pre-electrical stimulation (pre-ES, a 5-
min interval just prior to electrical stimulation) and post-
ES (a 5-min interval immediately after stimulation) stages
were also collected, transformed into frequency histogram
(Figure 3) ,a n da n a l y z e db yX c t i o nv i e ws o f t w a r e( Figure 4)
[15].Forelectricalstimulation,a10-minelectricsquarewave
pulse current with 0.1ms duration, 10Hz frequency, 0.1mA
intensity [15, 17, 22, 25] was applied through a constant
current unit.
2.4.TissuePreparationandImmunohistochemistry.Two hours
after electrical stimulation (or, in the control group, 2h after
nerve exposure), the rats were reanesthetized and perfused
with 500mL 4% paraformaldehyde in 0.1 M phosphate
buﬀer (PB) at pH 7.4. The brain stems containing the CN
were removed, postﬁxed with the same ﬁxative for 2hr and
stored in PB containing 30% sucrose. The tissue blocks
were cut transversely into 30-μm-thick serial sections and
orderly divided them into four sets. Two of the four serial
sections were treated with 1% H2O2 and blocked with 5%
normal goat serum in 0.1 M PB containing 0.2% Triton
X-100 for 2hr. They were incubated alternatively in rabbit
polyclonal anti-NPY (1:2000; DiaSorin, Stillwater, Mont,
USA) [16, 22, 26] or anti-c-Fos (1:2000, Calbiochem,
San Diego, Calif, USA) antibodies at 4
￿Cf o r4 8 h r .A f t e r
several washing with phosphate buﬀered saline (PBS), the
sections were processed with biotinylated anti-rabbit IgG
secondary antiserum (Vector, Burlingame, Calif, USA) at
room temperature for 2hr, treated with avidin-biotin-HRP
complex (ABC kit, Vector) for 1hr, and visualized with
a Vector SG Substrate Kit. Finally, they were mounted
onto gelatinized slides and their images were captured with
a digital camera (Nikon, D1X, Tokyo, Japan) through a
light microscope (Zeiss, Axiophot, Goettingen, Germany) to
measure the NPY-LI ﬁbers or c-Fos-LI cells in the CN.Anesthesiology Research and Practice 3
Table 1: Statistical comparison of mean values of the nerve
discharges.
Group Pre-ES Post-ES
Control 8.21
￿ 0.48Hz 7.65
￿ 0.95Hz
Presaline 91.86
￿ 4.39Hz 137.39
￿ 23.90Hz
￿
Pre-1% lido 50.31
￿ 2.90Hz 56.86
￿ 2.97Hz
￿
Pre-5% lido 23.76
￿ 0.57Hz 32.86
￿ 2.10Hz
￿
Control: sham operation with electrophysiological recording at the corre-
sponding stages. ES: electrical stimulation. Data are presented as mean
￿
standard error of the mean (SEM) and
￿P
￿ 0.05 compared with the pre-ES
stage.
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Figure 1: Eﬀects of pre-emptive treatment of saline or various
concentrations of lidocaine on paw withdrawal threshold in CCI
rats.Pre-treatment oflidocaineincreasedpaw withdrawalthreshold
and attenuated the TH in CCI rats.
￿P
￿ 0.05 compared to the
presaline group.
2.5. Data Presentation and Statistical Analysis. All measure-
ments of the behavior tests, rates of injury discharges, NPY-
LI ﬁbers, and c-Fos-LI cells in the CN were performed
blind to drug treatments. The behavior test of the Von Frey
ﬁlaments was compared between groups at each time point
and statistical analysis was performed with the Student’s t-
test. P
￿ 0.05 was considered as signiﬁcant.
The rate of nerve discharges was presented as the
number of discharges divided by the time period of the
respective stages and presented as mean
￿ SEM. In order
to investigate the inter-pre-treatment group (Figure 3)a n d
interstage (Table 1)d i ﬀerences, the rates of discharges were
compared with two-way ANOVA with a Newman-Keuls
posthoc test. P
￿ 0.05 was considered statistically signiﬁcant.
For quantitative analysis, the sections of middle CN,
which was deﬁned as an area 0.3–0.7mm caudal to the
obex [16–18, 27],were collectedfrom theentire rostrocaudal
extent of the CN. Four sections were collected from the
middle region of each animal. To assess the changes in
NPY and c-Fos immunoreactivity in the CN, sections were
investigated with a Zeiss light microscope and images were
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Figure 2: Electrophysiological recording of chronic constricted
median nerves at pre- and postelectrical stimulation, (pre-ES
and post-ES) stages. Data were collected and transformed into
frequency histogram for control (a), presaline (b), pre-1% lido (c),
and pre-5% lido (d) groups. Original recordings presented above
the histogram, respectively. Note that the rates of discharges were
signiﬁcantly reduced with increasing concentrations of lidocaine
pre-treatment.
captured with a Nikon digital camera at a magniﬁcation
of 200X. Pictures were processed and evaluated with a
computer-based image analysis system (MGDS) and Image
Pro-Plus software (Media Cybernetics, Md, USA). The area
occupied by NPY-LI ﬁbers and the area of outlined CN were
measured [15, 16, 22]. The former divided by the latter
was deﬁned as the percentage of area occupied by NPY-LI
ﬁbers in the ipsilateral CN and were compared statistically,
using two-way ANOVA, with the Newman-Keuls post-test
between pretreatment groups (electrically stimulated and
nonelectrically stimulated) (Figure 5). The mean number
o fc - F o s - L Ic e l l si nt h eC Nw a sd e ﬁ n e da st h en u m b e r
of the surveyed c-Fos-LI cells divided by the number of
tissue sectionsandwere calculatedand statistically compared
with one-way ANOVA and posthoc with the Newman-
Keuls test in the respective groups (Figure 7). In order to
clarify the relationship between c-Fos-LI cells and the NPY
reduction level caused by electrical stimulation (deﬁned
as the ratio of the NPY-LI ﬁbers occupied area in the
nonstimulated rat minus that in the stimulated rats in
diﬀerent treatment groups), the mean number of c-Fos-LI
cells and NPY reduction level of the individual rats were
collected and analyzed by linear regression (Figure 8). In
order to examine the relationship between c-Fos-LI cells and
mechanical allodynia, the mean number of c-Fos-LI cells
in the CN and mechanical withdrawal scale (deﬁned as the4 Anesthesiology Research and Practice
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Figure 3: Average rate of discharges (spikes/sec) in diﬀerent treat-
ment groups at pre-electrical stimulation (pre-ES), and postelectri-
cal stimulation (post-ES) stages. The rates of discharges decreased
with increasingdoses oflidocainepre-treatment compared with the
presaline group (
￿P
￿ 0.05 compared with the presaline group).
logarithm of paw withdraw threshold to the base 10 and
presented as log10-gram) of the individual rats were analyzed
by linear regression (Figure 9).
3.Results
3.1. Eﬀect of Lidocaine Pretreatment on Mechanical Allodynia
of the CCI Rats. Von Frey ﬁlament assessment demonstrated
that there were no signiﬁcant diﬀerences between bilateral-
CCI and unilateral-CCI in mechanical allodynia throughout
the experiment period. Von Frey ﬁlament tests also showed
that in CCI rats, paw withdrawal thresholds decreased from
a control of 14.83
￿ 1.14g to 0.75
￿ 0.20g at three days
after CCI in the presaline group. Rats established mechanical
allodynia three day after CCI, and throughout the 28-
day experiment period (control: 15.53
￿ 1.26g, presaline:
0.75
￿ 0.20g, Figure 1). However, pretreatment of lidocaine
to CCI increased paw withdrawal threshold and attenuated
the tactile hypersensitivity (TH) (Figure 1).
3.2.EﬀectofLidocaine PretreatmentonInjuryDischarges ofthe
Chronic Constriction Injured Median Nerves. At 29 days after
CCI, electrophysiological recording was used to examine
the changes in discharges of the median nerves before and
after electrical stimulation (pre-ES and post-ES stages) in all
groups (Figure 2). The nerves in the control group displayed
a few spikes at pre-ES and post-ES stages (Figure 2(a)).
Following median nerve CCI, the rates of discharges at both
pre-ES and post-ES stages in all CCI groups increased on the
injured nerves (Figures 2(b)–2(d)). Two-way ANOVA of the
rate of discharges displayed signiﬁcant diﬀerences between
diﬀerent stages (F
￿ 15.09, P
￿ 0.05) and between the
pretreatment groups (F
￿ 47.98, P
￿ 0.0001). The rates
o fd i s c h a r g e sa tt h ep o s t - E Ss t a g ew e r es i g n i ﬁ c a n t l yh i g h e r
than that at the pre-ES stage in all CCI groups, respectively
(Table 1). Of note, the rates of discharges at both pre-ES
and post-ES stages in presaline and pre-1% lido CCI gro-
ups were dramatically higher than those in the control
group (Figure 3). Furthermore, the rates of discharges in
all the lidocaine pretreatment groups at pre-ES (pre-1%
lido: 50.31
￿ 2.90Hz, pre-5% lido: 23.76
￿ 0.57Hz) and
post-ES (pre-1% lido: 56.86
￿ 2.97Hz, pre-5% lido: 32.86
￿
2.10Hz) stages were signiﬁcantly lower than those in the
presaline group (pre-ES: 91.86
￿ 4.39Hz; post-ES: 137.39
￿
23.90Hz), and revealed a dose-dependent suppression man-
ner (Figure 3).
3.3. Eﬀect of Lidocaine Pretreatment on NPY and c-Fos Exp-
ression in the Cuneate Nucleus. There were little to no NPY-
LI ﬁbers in the CNof uninjured control rats, with orwithout
electrical stimulation (control, 0.13
￿ 0.01%; control + ES,
0.14
￿ 0.03%; Figures 4(a), 4(b),a n d5). However, in the
presaline group, numerous NPY-LI ﬁbers were detected in
themiddleCNfourweeksafterCCIinboththeunstimulated
(30.62
￿1.21%)and stimulated(22.53
￿4.44%)sides(Figures
4(c), 4(d),a n d5). The percentage of NPY-LI ﬁbers in the
lidocaine pretreatment CCI groups in both the unstimulated
(pre-1% lido, 19.81
￿2.03%; pre-5% lido, 6.04
￿1.63%) and
stimulated (pre-1% lido, 12.12
￿ 4.07%; pre-5% lido, 4.26
￿
0.78%)sidesoftheCNweresigniﬁcantlydecreasedinadose-
dependent manner compared with those in the presaline
group (Figures 4(c)–4(h) and 5). Furthermore, in all CCI
groups the amount ofNPY-LI ﬁbers in the unstimulated side
of the CN (Figures 4(c), 4(e), 4(g),a n d5)w a ss i g n i ﬁ c a n t l y
higher than that in the stimulated side of the CN (Figures
4(d), 4(f), 4(h),a n d5), respectively, except for the pre-5%
lido group.
No, or only very few, c-Fos-LI cells were found in the
CN of the control rats, the median nerves with or without
electrical stimulation, or in CCI rats without electrical
stimulation (Figure 6(a)). However, numerous c-Fos-LI cells
were detected when injured median nerves treated with
electrical stimulation in all CCI groups and predominantly
distributed in the ventral portion of the middle CN
(Figure 6). Furthermore, quantitative analysis showed that
the mean number of c-Fos-LI cells in the presaline group
(42.9
￿ 2.8 cells) was signiﬁcantly greater than that in other
groups (Figures 7(b) and 8). The mean number of c-Fos-LI
cells in the CN was also reduced by lidocaine pretreatment
in a dose-dependent manner (pre-1% lido, 26.6
￿ 1.6 cells;
pre-5% lido, 18.5
￿ 1.4 cells) (Figures 6(c), 6(d),a n d7).
In addition, the NPY reduction level was assessed by the
percentage of NPY-LI ﬁbers in the stimulated side of the
CN subtracted from that in the unstimulated side of the
CN, regarded as an index of the extent of NPY release by
electrical stimulation. Statistical analysis by linear regression
demonstrated that the mean number of c-Fos-LI cells in
the stimulated side of the CN was signiﬁcantly correlated
to the NPY reduction level (Figure 8, r
￿ 0.64, P
￿ 0.01).
Finally, linear regression manifested that the mean number
of c-Fos-LI cells in the CN was negatively proportional to
the mechanical withdrawal scale (Figure 9, r
￿
￿0.80, P
￿
0.005).Anesthesiology Research and Practice 5
(a) (b) (c)
(d) (e) (f)
(g) (h)
Figure 4: Photomicrographs showing NPY-LI ﬁbers in the middle region of the ipsilateral CN four weeks after chronic constriction injury
in control (a, b) or four weeks after CCI without (left panel) or with (rightpanel) electrical stimulationinpresaline (c, d), 1% (e, f), and 5%
(g, h) lidocaine pre-treatment groups. Bar = 100μm.
4.Discussion
The results of the present study demonstrate the attenuation
of TH and reduction of injury discharges following CCI on
median nerves by lidocaine pretreatment. Correspondingly,
boththeleveloftheinjury-induced NPYﬁbersandthenum-
ber of injury-induced c-Fos-LI cells in the CN at four weeks
after medina nerve CCI were also dose-dependently reduced
by lidocaine pretreatment. These results provide a possible
mechanism in that the suppression of injury discharges by
lidocaine pretreatment not only relieves neuropathic pain
b u ta l s oa t t e n u a t e st h eN P Ya n dc - F o se x p r e s s i o n si nt h eC N
after CCI.
Followingmedian nerveCCI,signs ofmechanical allody-
nia were detected three days after CCI and lasted throughout
theexperimentperiodof28daysinthepresentstudy.Similar
results have been reported, where hyperalgesia responses
to noxious radiant heat were observed on the second
postoperativedayandlasted forovertwomonths after sciatic
nerve CCI [3]. Another study also indicated that mechanical
allodynia was found three to ﬁve days following CCI [28],
whereas this neuropathicsign wasdetectedone dayafter CCI
in our recent study [22]. There are discrepancies in the time
points of neuropathic pain initiating after CCI between vari-
ousstudies.Thereasonforthesediscrepanciesmaybesimply
due to diﬀerent time points being examined. We focused on
the role of lidocaine pretreatment in the paw withdrawal
threshold of the CCI rats. The reductions in the paw
withdrawal threshold after median nerve CCI were reversed
by lidocaine pretreatment in a dose-dependent manner.6 Anesthesiology Research and Practice
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Figure 5: Histograms showing morphometric assessments used to quantify intensity of NPY-LI ﬁbers in the middle CN at four weeks after
chronic constriction injury without (CCI) or with electrical stimulation (CCI + ES). It is notable that the intensities of NPY-LI ﬁbers in the
CN were signiﬁcantly lower in rats with electrical stimulation than those without stimulation in the presaline and pre-1% lidocaine groups
(
#P
￿ 0.05 compared with unstimulated side in respective group). The intensity of NPY-LI ﬁbers in the CN was also reduced by lidocaine
pretreatment in a dose-dependent manner(
￿,
￿P
￿ 0.05compared with the stimulated andunstimulated side of the presaline group, resp.).
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Figure 6: Photomicrographs showing c-Fos-LI cells in the middle region of the CN ipsilateral to electrical stimulation four weeks after
chronic constriction injury in control (a), presaline (b), pre-1% lido (c) and pre-5% lido (d) groups. Bar = 100μm.Anesthesiology Research and Practice 7
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Figure 8: Linear regression of the mean number of c-Fos-LI cells
and NPY reduction level in the CN four weeks after chronic
constriction injury (each point represents an individual animal;
r
￿ 0.64, P
￿ 0.01).
Ap r e v i o u ss t u d y[ 6] reported that lidocaine pretreatment
relieved thermal hyperalgesia for a long postoperative period
(uptothree weeks) aftersciatic nerveCCI.However, another
studyshowedthatpriortospinal nerveligation(SNL),ligno-
caine pretreatment increased the paw withdrawal threshold
for only 24h [29]. These discrepancies may be related to
diﬀerencesintheinjurymodelsusedintheabove-mentioned
studies (CCI versus SNL). The lesion site to the DRG in the
CCI model was more distal than that in the SNL model. The
injury level caused by the former was less severe than that by
the latter, so the neuropathic pain induced by the CCI model
could be prevented by lidocaine pre-treatment.
Furthermore, four weeks after CCI (29 days postinjury),
a signiﬁcant increase in the number of spikes in all CCI
groups, which was regarded as ectopic discharges induced
after nerve injury. Then, our results also demonstrated that
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Figure 9: Linear regression of the mean number of c-Fos-LI cells
and mechanical withdrawal scale (presented as log10-gram) four
weeks after chronic constriction injury (each point represents an
individual animal;r
￿
￿0.80, P
￿ 0.005).
the ectopic discharges were suppressed by lidocaine pre-
treatment in a dose-dependent manner. The suppression in
ectopic discharges was considered as one of the contributing
factors in relieving neuropathic pain induced by median
nerve CCI. Our recent study reported that ectopicdischarges
evokedby mediannervetransection (MNT)were suppressed
by pre-treatment with 5% and 10% lidocaine, but not
1% lidocaine [15]. However, in the present study, ectopic
discharges induced by CCI were signiﬁcantly attenuated
by 1% lidocaine pre-treatment. This discrepancy may also
be explained by the diﬀerence in injury model employed
between these two studies. The injury severity induced by
CCI was milder than that by MNT. For this reason, the rate
of injury discharges in the CCI rats, but not MNT, could
be signiﬁcantly reduced by low-dose (1%) lidocaine pre-
treatment.
The presentstudyfurther demonstratedthata signiﬁcant
increase in NPY in the CN at four weeks (29 days) post-
CCI was also dose-dependently reduced by lidocaine pre-
treatment. Previous studies have reported that intense aﬀer-
ent discharges and depolarization enhanced NPY induction
[30, 31]. Furthermore, the NPY induction in the CN exclu-
sively originated from injured DRG neurons, particularly
medium- and large-size neurons, via primary aﬀerent ﬁbers
[26]. It is reasonable to infer that the reduction of NPY
expression in the CN would result from the suppression
in injury discharges following CCI with lidocaine pre-
treatment. This is consistent with NPY reduction in the CN
after MNT [15] with lidocaine pre-treatment and in the
spinal cord laminae 3-4 following sciatic nerve CCI with
MK-801 and clonidine pre-treatment [30]. Taken together,
these ﬁndings suggestthatthe magnitudeofnervedischarges
may be one of the most important factors to induce NPY
synthesis.
In the rats with bilateral median nerve CCI, c-Fos-LI
cells were found only in the CN with electrical stimulation,
but not in the unstimulated side of the CN; the level of8 Anesthesiology Research and Practice
NPY-LI ﬁbers in the stimulated side of the CN was also
signiﬁcantly lower than that in the unstimulated side. One
possible explanation for this is that NPY is released from
the injured median nerve in the stimulated side of the CN
resulting in NPY reduction and induced c-Fos expression in
the same region. This is compatible with previous studies
where NPY reduction and c-Fos induction were detected in
thestimulated sideofthe CNfollowing electrical stimulation
with the transected median nerve; injection of an NPY
receptor antagonist into the CN coupled with electrical
stimulation to the injured nerve resulted in a dramatic
decrease in the number of c-Fos-LI cells in the ipsilateral CN
[15, 22]. In the present study, we also found that the number
of c-Fos-LI cells in the CN after electrical stimulation of the
injured nerve was dose-dependently reduced by lidocaine
pre-treatment. Statistical analysis further demonstrated that
the number of c-Fos-LI cells in the stimulated side of
the CN was signiﬁcantly correlated to the level of NPY
reduction. Taken together, these results suggest that the
amount of NPY release (NPY reduction level), following
electricalstimulationoftheinjurednerve,directlymodulates
c-Fos expression in the CN.
Although the function of c-Fos induction in the CN
remains uncertain, theexpression ofc-Fosimmunoreactivity
inthespinalcordhasbeenconsideredasaconvincingmarker
of pain [19, 20]. Our results showed that the number of c-
Fos-LI cells in the CN coincided with the reduction in paw
withdrawal thresholds, regarded as mechanical allodynia.
This is in agreement with a previous study which reported
that the number of c-Fos-LI cells was positively associated
with the magnitude of mechanical allodynia [22]. Earlier
studies have also clariﬁed that after electrical stimulation
of the injured median nerve, about 78% of c-Fos-LI cells
in the middle CN were cuneothalamic projection neurons
(CTNs) [17, 18]. This study further showed that the number
of c-Fos-LI cells was dose-dependently reduced by lidocaine
pre-treatment. Injury discharges have been reported to
be implicated in the increase of c-Fos LI cell expression
in the spinal cord dorsal horn [32–34], while lidocaine
pre-treatment attenuates the discharges to prevent c-Fos
induction [21, 34].
5.Conclusions
Our results suggest that lidocaine pre-treatment dose-
dependently suppressed injury discharges development to
attenuate NPY expression after median nerve injury. This
in turn signiﬁcantly reduces the NPY release to decrease the
transmitting of TH to the thalamus and c-Fos expression in
the CTNs.
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